Joe Biden’s advanced prostate cancer diagnosis comes with a chilling 30-40% five-year survival rate, proving once again that medical transparency matters far more than the political theater we’ve endured for years.
At a Glance
- Biden has been diagnosed with aggressive prostate cancer (Gleason score 9) that has spread to his bones
- The 82-year-old former president faces a 30-40% five-year survival rate
- His diagnosis comes after experiencing increasing urinary symptoms
- The cancer is hormone-sensitive, allowing for treatment options including hormone therapy and radiation
- Biden had to drop out of the 2024 presidential race, with timing that raises serious questions about what the public was told
The Diagnosis They Didn’t Want You to Know
It seems that important medical information always comes out when it’s politically convenient, doesn’t it? After years of media gaslighting about Biden’s health and cognitive abilities, we now learn that the 82-year-old former president has aggressive prostate cancer with bone metastasis. Biden’s office confirmed last week that he “was seen for a new finding of a prostate nodule after experiencing increasing urinary symptoms.” The diagnosis is characterized by a Gleason score of 9 (Grade Group 5), representing one of the most aggressive forms of the disease. This revelation raises obvious questions about what the American people were told – or more importantly, what they weren’t told – during the painful years of his presidency.
While medical privacy is important for any individual, the timing here is impossible to ignore. Biden mysteriously dropped out of the 2024 presidential race amid mounting concerns about his mental and physical capabilities, being quietly replaced by Kamala Harris. Now suddenly we learn about a serious cancer diagnosis. The American people deserved transparency about the health of the person supposedly running the country, especially when that person already showed obvious signs of cognitive decline captured on camera for all to see. But instead, we got cover-ups, denial, and media protection.
Understanding the Severity of Biden’s Condition
Dr. Marc Siegel didn’t mince words when describing Biden’s condition: “It’s the most aggressive type.” With a Gleason score of 9 and metastasis to the bones, Biden faces a five-year survival rate between just 30% and 40%. This isn’t your typical prostate cancer found in aging men – this is a serious, advanced disease that typically requires aggressive treatment. The cancer was discovered through a physical prostate exam, not just through blood tests, indicating that it had already progressed significantly. The presence of urinary symptoms further confirms the advanced nature of the disease.
“This was found by physical examination by a prostate exam,” – Dr. Marc Siegel.
The bone metastasis is particularly concerning. When prostate cancer spreads to the bones, it can cause significant pain and further complications. If Biden was experiencing these symptoms during his presidency, it raises serious questions about his ability to perform his duties effectively. And yet, his administration and their media allies continually attacked anyone who questioned his fitness for office. The American people were owed honesty, not politically-motivated medical obfuscation about the condition of the man with access to the nuclear codes.
Treatment Options and Prognosis
Biden’s diagnosis indicates the cancer is hormone-sensitive, which does provide options for management. Treatment will likely include hormone therapy, potentially radiation, and possibly even prostate removal, though at 82 years old, surgery carries additional risks. Medications like Lupron and Casodex are common treatments for advanced prostate cancer, though they come with side effects including fatigue – certainly not ideal for someone already showing signs of reduced energy and mental acuity.
“The goal is to get it before it leaves the prostate,” – Dr. Marc Siegel.
While Biden’s office tries to strike an optimistic tone, noting that the cancer “appears to be hormone-sensitive which allows for effective management,” we can’t ignore the reality of the 30-40% five-year survival rate. This sobering statistic underscores why prostate cancer screening is crucial for men over 45. Early detection dramatically improves outcomes, with localized prostate cancer having much higher survival rates. The American people deserve leaders who take health screening seriously and who are transparent about health issues that might impact their ability to serve. More importantly, they deserve to know the truth about the health of their president.
